Search

Issue
Title
Authors
Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: A retrospective study
Semenov N.N., Izrailov R.E., Semenov N.E., Zhukova L.G., Feoktistova P.S., Matveychuk D.A., Khatkov I.E.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I.V., Poddubnaya I.V.
Perioperative chemotherapy and morphological response in the treatment of gastric cancer: A retrospective study
Kiselev N.M., Klimin S.A., Kolesnik Y.I., Kokorin R.S., Ashimov E.А., Elagina V.Y., Shumskaya I.S., Zagainov V.E., Gamayunov S.V.
The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study
Khatkov I.E., Semenov N.N., Izrailov R.E., Efanov M.G., Dalgatov K.D., Zhukova L.G.
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
Kolyadina I.V., Abidova N.R., Akopyan A.A., Antonova G.V., Arapova O.I., Bobrova E.A., Bolotina L.V., Valiakhmetova C.K., Vasilevskaya A.V., Vladimirova L.Y., Volkonskiy M.V., Ganshina I.P., Gudkova I.E., Dergunov A.S., Evstigneeva I.V., Egurenkova V.S., Emshanov A.V., Zhukova L.G., Zueva E.V., Karabina E.V., Kolokolov J.J., Kuzmicheva S.V., Kuchevskaya O.A., Luev I.A., Maistrenko K.S., Markizova E.V., Marfutov V.V., Medvedev S.P., Merzlikina Y.I., Nersesova T.A., Ovchinnikova E.G., Orlova S.A., Samaneva N.Y., Stativko O.A., Storozhakova A.E., Stroyakovskiy D.L., Sultanbaev A.V., Tekeeva A.I., Fadeeva N.V., Fedorova A.N., Shalaeva O.M., Shangina I.A., Shirokova O.N., Shumskikh A.R., Yakubova M.Z.
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Multiple myeloma
Mendeleeva L.P., Votiakova O.M., Rekhtina I.G., Osmanov E.A., Poddubnaya I.V., Grivtsova L.I., Falaleeva N.A., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Dermatological toxicity in the treatment of malignant tumors in children: A review
Belysheva T.S., Shatokhina E.A., Komarova A.D.
Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Ganshina I.P., Khokhlova S.V., Kоmetova V.V., Rodionov V.V.
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N.I., Vladimirova L.I., Kolyadina I.V., Frantsiyants E.M., Storozhakova A.E., Bandovkina V.A., Kalabanova E.A., Kabanov S.N., Svetitskaya I.V., Tishina A.V., Ezhova M.O.
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
Kolyadina I.V., Ganshina I.P., Kuzmicheva S.V., Tekeeva A.I., Kolokolov J.D., Volkonskii M.V., Poddubnaya I.V.
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
Ognerubov N.A., Barsukov S.V.
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial
Levashov A.S., Zagidullina S.R., Stroganova A.M., Khochenkov D.A., Ryzhova M.V., Gorelyshev S.K., Kadirov S.U., Babelyan S.S., Grigorenko V.A., Sidel’nikov D.A., Subbotina N.N., Daylidite V.V., Mentkevich G.L.
Perioperative chemotherapy for gastric cancer: the current state
Lyadov V.K., Pardabekova O.A., Lyadova M.A.
Systemic drug therapy of metastatic pancreatic cancer
Pokataev I.A., Tyulyandin S.A.
High-dose chemotherapy with hematopoietic stem cell rescuein children older than 3 year with medulloblastoma: results of single institution trial
Babelyan S.S., Subbotina N.N., Dolgopolov I.S., Gorelyshev S.K., Mentkevich G.L., Byarshinov V.K., Pimenov R.I.
Which chemotherapy treatments are best for helping people with advanced pancreatic cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Kinaly I.
Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review
Dinikina Y.V., Zheludkova O.G., Ryzhova M.V., Olhova L.V., Korneev D.Y., Belogurova M.B.
Alopecia prevention during chemotherapy: from the benchmark to real clinical practice. A prospective study
Lyadova M.A., Nersesova T.A., Zhuravleva A.A., Fedorinov D.S., Dudnik A.A., Denisova E.A., Nosova M.V., Pardabekova O.A., Lisitsyna K.N., Tuleiko V.M., Bikmurzina O.A.
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Ognerubov N.A.
Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Zaleeva A.R.
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus
Shogenov M.S., Davydov M.M., Allakhverdiyev A.K., Chekini A.K., Filatov A.A., Akhmedov P.I., Serebryanskaya M.V., Korolyeva A.A., Dadyev I.A., Chichikov E.I., Grigorenko V.A., Kozlov N.A., Nazliyev P.B., Malikhova O.A., Tryakin A.A.
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Fedyanin M.I.
The role of angiogenesis blockers in the treatment of metastatic ovarian cancer
Oganian M.R., Kazantseva M.V., Davidenko I.S., Porhanova N.V.
First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx
Stativko O.A., Pokataev I.A., Kravtsov S.A., Zhukova L.G., Stroyakovskiy D.L., Sabitov E.R., Kuzmina E.S., Feoktistova P.S., Antonova T.G., Lyadova M.A., Nosova M.V., Sydykova R.S., Lisitsyna K.N., Strelnikova T.B., Alizade G.R., Parts S.A., Dolov M.M., Tedeeva A.K., Galkin V.N.
Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polianskii M.B., Pis'mennaia E.V.
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review
Dinikina Y.V., Zheludkova O.G., Belogurova M.B., Spelnikov D.M., Osipov N.N., Nikitina I.L.
Creating a story on the pages of a book about diffuse B-large cell lymphoma
Editorial B.
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
Reutova E.V., Laktionov K.K.
Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor
Ganshina I.P., Ivanova K.A., Lubennikova E.V., Arkhipov A.V., Zhukova L.G.
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
The role of cytoreduction surgery in advanced ovarian cancer (review)
Tandelov R.K., Sel'chuk V.Y., Morkhov K.Y., Nechushkina V.M., Kuznetsov V.V.
The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
Motalkina M.S., Kulyova S.A., Alexeev S.M., Zuzgin I.S., Filatova L.V., Zhabina A.S., Zverkova A.A., Ishmatova I.V., Rjazankina A.A., Artemyeva A.S., Semiglazova T.Y.
New chemotherapy options for triple-negative breast cancer (review of literature)
Sekundova M.A., Zdvizhkov A.M., Borisov V.I.
What are the harms and benefits of using pegylated liposomal doxorubicin in women with recurrent epithelial ovarian cancer, alone or in combination with other drugs? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
Effectiveness and safety of empegfilgrastim (Extimia®) in patients with solid tumors receiving cytotoxic therapy: final results of the DEFENDOR study
Snegovoy A.V., Kononenko I.B., Radiukova I.M., Orlova S.A., Sultanbaev A.V., Dubovichenko D.M., Dergunov A.S., Saidullaeva A.F., Repina N.N., Gronskaia I.A., Rossokha E.I., Starostina T.V., Akimova O.V., Vasil'eva I.A., Godzhieva Z.A., Garanina O.I., Gorchkhanova K.I., Machekhina I.S., Gracheva A.S., Danilova A.E., Dmitrakova T.N., Dmitriev V.N., Dmitrochenko M.V., Dylinova O.V., El'kova V.O., Zhelezniak A.V., Zubova I.V., Ivanov A.N., Kaleikina L.P., Komoza I.V., Korolev D.N., Lebedeva L.N., Lebedinets A.A., Mamedguseinova N.N., Miagkova V.S., Matiushina E.I., Narovenkova K.V., Nikolaeva V.M., Novikov D.V., Polonskaia G.E., Rebrina O.V., Safronova M.A., Semenova A.S., Semenova I.A., Skotnikov R.A., Solov'eva E.P., Tat'ianenko A.N., Teterich A.A., Timin V.N., Tolmacheva I.A., Tiugina I.A., Khodkevich A.V., Tsarakhova F.V., Chapko I.S., Shegurova M.M., Shakurova N.R., Shalina A.I., Shumilkina E.A., Iakuba D.V., Ibragimova T.M., Feoktistova P.S., Sorokina I.V., Berezina A.M., Kiseleva P.V., Mironenko O.N., Prosianikova O.N.
International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review)
Levashov A.S., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V.A., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadyrov S.U., Polyakov V.G.
Modern strategy of treatment of patients with retroperitoneal sarcomas: A review
Stilidi I.S., Nikulin M.P., Kalinin O.E., Abgiarian M.G., Vashakmadze L.V., Fainshtein I.A., Arkhiri P.P., Salimova A.A.
Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
Brish N.A., Semiglazova T.Y., Karachun A.M., Shevkunov L.N., Ulyanchenko Y.A., Artemyeva A.S., Golovanova T.S., Tkachenko E.V., Alexeeva Y.V., Sharashenidze S.M., Strakh L.V., Protsenko S.A., Teletaeva G.M., Filatova L.V., Kasparov B.S., Semiglazov V.V., Belyaev A.M.
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I.P., Gordeeva O.O., Manukian M.S.
Modern ultrasound diagnostics for locally advanced cervical cancer
Ovodenko D.L., Khabas G.N., Makarova A.S., Pirogova M.S., Seregin A.A., Golitsyna Y.S., Ashrafyan L.A.
Diagnosis and treatment of malignant trophoblastic tumors: errors, dangers, complications (review of the literature)
Gasanbekova Z.A., Aliev S.A., Meshcheryakova L.A., Kozachenko V.P., Kuznetsov V.V.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.A.
Role of vemurafenib in the treatment of disseminated skin melanoma
Demidov L.V., Utyashev I.A., Kharkevich G.Y.
Comparison of efficacy and safety of regorafenib and anti-EGFR targeted therapy in metastatic colorectal cancer: A retrospective study
Kuzmina E.S., Fedyanin M.Y., Lyadova M.A., Fedorinov D.S., Polyanskiy M.A., Parts S.A., Pokataev I.A., Galkin V.N.
EDP chemotherapy combined with somatostatin analogues and mitotane in the treatment of disseminated adrenocortical carcinoma: a clinical case
Magamedova O.R., Oganesyan L.V., Feoktistova P.S., Feidorov I.Y.
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Lyadova M.A., Fedorinov D.S., Kuzmina E.S., Antonova T.G., Sokolskaya V.K.
Neoadjuvant chemotherapy for treatment patients with rectal cancer with adverse prognostic factors: A review
Nevolskikh A.A., Avdeenko V.A., Belokhvostova A.S., Mikhaleva Y.Y., Pochuev T.P., Zibirov R.F., Ivanov S.A., Kaprin A.D.
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M.I., Fatyanova A.S., Meretukov D.A., Zhilenkova A.V., Rusanov A.S., Rozhkov A.A., Guryanova A.A., Bagmet N.N.
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.V.
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
Tolerability of perioperative chemotherapy for gastric cancer in real clinical practice
Fedorinov D.S., Lyadova M.A., Lyadov V.K.
Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study
Levashov A.S., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V.A., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadirov S.U., Polyakov V.G.
CT sarcometry in the prediction of postoperative complications in patients with gastric cancer: Retrospective cohort study
Agababyan T.A., Kukarskaya V.A., Silanteva N.K., Potapov A.L., Skoropad V.Y., Sheberova E.V., Dorozhkin A.D., Ivanov S.А., Kaprin A.D.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary)
Uvarova K.G.
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
Demina E.A.
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
Dalgatov K.D., Semenov N.N., Kozodaeva M.V.
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy
Vladimirova L.Y., Mitashok I.S., Snezhko T.A., Samaneva N.Y., Storozhakova A.E., Kornilova I.S.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients
Romanenko N.A.
Neoadjuvant chemotherapy with FLOT scheme in surgical treatment of gastric cancer: short- and long-term outcomes. A retrospective cohort study
Osminin S.V., Vetshev F.P., Bilyalov I.R., Kozlova A.I., Sutin A.P., Astaeva M.O., Eventeva E.V.
Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment
Fedyanin M., Rumyantsev A.A., Tryakin A.A.
Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review
Ognerubov N.A.
Endoscopic esophageal stenting in combination with chemoradiation therapy: A review
Ivanov A.I., Popov V.A., Burmistrov M.V.
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
Mochkin N.E., Sarzhevskiy V.O., Dubinina J.N., Smirnova E.G., Fedorenko D.A., Bannikova A.E., Kolesnikova D.S., Bogatyrev V.S., Samoylova A.A., Faddeev N.M., Melnichenko V.Y.
A method of laparoscopic installation of port systems for intra-abdominal chemotherapy in patients with advanced ovarian cancer
Lozovaya V.V., Cherkes L.V., Malikhova O.A., Poddubny B.K.
Liposarcomas: morphological subtypes, prognostic factors and therapeutic options
Fedenko A.A.
The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases
Bryuzgin V.V., Platinskij L.N.
1 - 77 of 77 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».